Location:
Berg Family Foundation Seminar Room, Level 6, Wallace Wurth Building, Kensington Campus
Contact for enquiries
Rata Joseph, +61 (2) 9385 0900 or recpt@kirby.unsw.edu.au
Kirby Institute Seminar Series presents
 |
PhD Student, Viral Hepatitis Epidemiology and Prevention Program, Kirby Institute Hao Bui is undertaking her PhD at the Kirby Institute under the supervision of Professor Lisa Maher and Associate Professor Iryna Zablotska-Manos. Her thesis focuses on estimating HIV prevalence, understanding HIV risk behaviour and barriers to HIV testing and ART uptake of men who have sex with men in Hanoi, Vietnam. |
|
 |
||
 |
Research Assistant, Viral Hepatitis Epidemiology and Prevention Program, Kirby Institute Louise Geddes is a Research Assistant and PhD Student at the Kirby Institute, UNSW. Louise currently works on New South Wales NSP Enhanced Data Collection project which collects data from NSP attendees in NSW. Her particular research interest is opioid use among people who inject drugs. |
Abstracts
Prevalence and correlates of HIV infection among men who have sex with men in Hanoi, Vietnam
Ms Hao Bui
Despite advances in HIV biomedical prevention, men who have sex with men (MSM) remain at high risk of HIV infection globally. In Vietnam, where there are concerns that HIV in MSM is increasing, estimates of prevalence and understanding of risk factors in this population remain limited. In this session, Hao will present the results of a baseline survey estimating HIV prevalence among MSM in Hanoi, Vietnam and estimate factors associated with prevalent HIV infection in this population.
Sex discrepancies in the protective effect of opioid agonist therapy on hepatitis C infection
Miss Louise Geddes
Recent research suggests that the protective effect of opioid agonist therapy (OAT) may be attenuated in females compared to males. Using data from the InC3 project, this study assessed sex disparities in hepatitis C virus incidence among people who inject drugs exposed to OAT and factors independently associated with decreased protective efficacy.
Viral Hepatitis Epidemiology and Prevention Program, Kirby Institute" />